Supreme Court sides with Monsanto in case over cancer risks from weedkiller Roundup
Washington — On Thursday, the Supreme Court issued a landmark ruling in the case Monsanto Co. v. Durnell, determining that Monsanto cannot be held liable under state laws for failing to warn consumers about the potential cancer risks associated with its popular weedkiller Roundup. The 7-2 decision centered around a federal law that governs the sale and labeling of pesticide products, ultimately barring state court lawsuits alleging inadequate warning labels on Roundup.
The Environmental Protection Agency (EPA) has consistently affirmed the safety of Roundup, deeming it safe for use without the need for a cancer warning on its label. The Supreme Court emphasized that federal law requires Monsanto to adhere to an EPA-approved label, with no additional warnings necessary unless mandated by the EPA.
Justice Brett Kavanaugh delivered the majority opinion, joined by Chief Justice John Roberts and Justices Samuel Alito, Sonia Sotomayor, Elena Kagan, Amy Coney Barrett, and Clarence Thomas. Justices Ketanji Brown Jackson and Neil Gorsuch dissented from the ruling.
Following the acquisition of Monsanto by Bayer in 2018, the company has been embroiled in numerous legal battles related to Roundup. The Supreme Court’s decision is anticipated to halt a significant number of lawsuits from individuals who alleged that Monsanto failed to adequately warn them about the potential cancer risks associated with the product.
In response to the ruling, Bayer expressed its support, stating that the decision would help bring closure to the Roundup litigation after years of legal disputes. The company also highlighted its ongoing efforts to secure final approval for a $7.25 billion class settlement proposed earlier this year to address current and future Roundup-related claims.
Background of the Supreme Court Case
The case was initiated by John Durnell, a Missouri gardener who filed a lawsuit against Monsanto in 2019, alleging that exposure to Roundup had led to his development of non-Hodgkin’s lymphoma. Durnell’s case was part of a larger wave of litigation against Monsanto, with numerous plaintiffs across the country attributing their cancer diagnoses to glyphosate, the key ingredient in Roundup.
Central to the legal dispute was the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA), a federal law enacted in 1947 to regulate pesticide use and labeling. FIFRA mandates that pesticide manufacturers register their products with the EPA and adhere to a uniform labeling framework.
Despite conflicting assessments from different entities regarding the carcinogenic potential of glyphosate, the EPA’s consistent determination of Roundup’s safety has been a focal point in the legal battles. While the International Agency for Research on Cancer classified glyphosate as “probably carcinogenic to humans” in 2015, the EPA’s evaluations have consistently supported the safety of the herbicide.
Following the EPA’s assessments, numerous lawsuits emerged, alleging that Roundup had caused various forms of cancer among users. Durnell’s case, which resulted in a $1.25 million damages award, underscored the complexity of balancing conflicting scientific opinions and regulatory requirements.
Implications and Political Context
The Supreme Court’s ruling represents a legal victory for the Trump administration, which supported Monsanto in the case and emphasized the EPA’s authority in determining pesticide warning requirements. However, the decision may present political challenges, particularly in light of growing concerns about pesticide use and environmental health.
President Trump’s executive order aimed at bolstering glyphosate-based herbicide production underscored the administration’s perspective on agricultural productivity and the need for access to key substances like glyphosate. The intersection of regulatory oversight, scientific evidence, and public health concerns continues to shape the dialogue surrounding pesticide use and labeling.
